Source comparison
Best Thymosin Alpha-1 Dosage Chronic Fatigue 2026: Treatment Comparison
Before starting any peptide protocol, understanding how different approaches compare. Dose, frequency, monitoring requirements. Helps set realistic expectations for timeline and cost. Standard Immune Restoration 1.6mg subcutaneous Twice weekly (every 3–4 days)
This comparison does not assign a generated winner or score.
- Before starting any peptide protocol, understanding how different approaches compare. Dose, frequency, monitoring requirements. Helps set realistic expectations for timeline and cost.
- Standard Immune Restoration
- 1.6mg subcutaneous
- Twice weekly (every 3–4 days)
- Immune panel at weeks 0, 8, 16
- 12–16 weeks
- 15–25% increase from baseline by week 12
- Best for moderate fatigue with confirmed immune dysfunction (CD4+ <500). Cost-effective, well-supported by clinical evidence.
- High-Dose Accelerated
- 3.2mg subcutaneous
- Immune panel at weeks 0, 6, 12
- 12 weeks
- 20–30% increase from baseline by week 8
- Reserved for severe immune depletion (CD4+ <350). Higher cost with marginal benefit over standard dose unless baseline is critically low.
- Maintenance Protocol
- Once weekly
- Immune panel every 12 weeks
- Ongoing (24+ weeks)
- Sustains normalised levels, doesn't increase further
- Used post-restoration to prevent relapse. Not appropriate as initial treatment. Start with twice-weekly, transition to maintenance only after normalisation.
- Low-Dose Experimental
- 0.8–1.2mg subcutaneous
- Twice weekly
- Immune panel at weeks 0, 12
- 16–24 weeks
- 5–10% increase, often not statistically significant
- Insufficient for meaningful immune restoration in published trials. Avoid unless cost is the overriding constraint and expectations are adjusted accordingly.